| CXSL2400639 | 重组安菲博肽注射液 | Anfibatide | Injection | Biological Products(1) | New Drug Application | 2024-09-25 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CXSL2400638 | 重组安菲博肽注射液 | Anfibatide | Injection | Biological Products(1) | New Drug Application | 2024-09-25 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CYHS2401143 | 舒更葡糖钠注射液 | sugammadex sodium | Injection | Chemical Drugs(4) | Generic Drug | 2024-04-17 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CYSB2400016 | 人干扰素α2b凝胶 | Recombinant Human Interferon α2b | Gel | Biological Products(原4) | Supplementary Application | 2024-01-12 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CYSB2400015 | 人干扰素α2b凝胶 | Recombinant Human Interferon α2b | Gel | Biological Products(原4) | Supplementary Application | 2024-01-12 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CYSB2200211 | 重组人干扰素α2b凝胶 | Recombinant Human Interferon α2b | Gel | Biological Products | Supplementary Application | 2022-08-23 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CYSB2200212 | 重组人干扰素α2b凝胶 | Recombinant Human Interferon α2b | Gel | Biological Products | Supplementary Application | 2022-08-22 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CYHL2200065 | 盐酸氨酮戊酸口服溶液用粉末 | aminolevulinic acid hydrochloride | Other | Chemical Drugs(3) | Generic Drug | 2022-08-16 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CYHS2101873 | 左卡尼汀注射液 | levocarnitine | Injection | Chemical Drugs(4) | Generic Drug | 2021-10-19 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CYHB2140520 | 注射用那屈肝素钙 | nadroparin calcium | Lyophilized | Chemical Drugs | Supplementary Application | 2021-08-03 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CYHB2140519 | 注射用那屈肝素钙 | nadroparin calcium | Lyophilized | Chemical Drugs | Supplementary Application | 2021-08-03 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CYHB2101014 | 曲前列尼尔注射液 | treprostinil | Injection | Chemical Drugs(4) | Supplementary Application | 2021-02-23 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CYHB2101013 | 曲前列尼尔注射液 | treprostinil | Injection | Chemical Drugs(4) | Supplementary Application | 2021-02-23 | | Zhaoke Pharmaceutical (Hefei) Co Ltd | | | view |
| CYHS2000798 | 那屈肝素钙注射液 | nadroparin calcium | Injection | Chemical Drugs(4) | Generic Drug | 2020-11-21 | 兆科药业（合肥）有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | In Review | 2020-11-20 | view |
| CYHS2000799 | 那屈肝素钙注射液 | nadroparin calcium | Injection | Chemical Drugs(4) | Generic Drug | 2020-11-21 | 兆科药业（合肥）有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | In Review | 2020-11-20 | view |
| CYSB2000052 | 重组人干扰素α2b凝胶 | Recombinant Human Interferon α2b | Gel | Biological Products | Supplementary Application | 2020-04-04 | 兆科药业（合肥）有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | In Review | 2020-04-03 | view |
| CYSB2000051 | 重组人干扰素α2b凝胶 | Recombinant Human Interferon α2b | Gel | Biological Products | Supplementary Application | 2020-04-04 | 兆科药业（合肥）有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | In Review | 2020-04-03 | view |
| CYHB1906892 | 注射用那屈肝素钙 | nadroparin calcium | Lyophilized | Chemical Drugs | Supplementary Application | 2019-12-13 | 兆科药业（合肥）有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Certificate Issued | 2020-08-03 | view |
| CYHB1906893 | 注射用那屈肝素钙 | nadroparin calcium | Lyophilized | Chemical Drugs | Supplementary Application | 2019-12-13 | 兆科药业（合肥）有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Certificate Issued | 2020-08-03 | view |
| CYHS1800500 | 磺达肝癸钠注射液 | fondaparinux sodium | Injection | Chemical Drugs(4) | Generic Drug | 2019-01-02 | 兆科药业（合肥）有限公司 | Zhaoke Pharmaceutical (Hefei) Co Ltd | Certificate Issued | 2021-02-05 | view |
